Cargando…

Patient's weight can decide about spending millions on enzyme replacement therapy in MPS II

Detalles Bibliográficos
Autores principales: Bik-Multanowski, Miroslaw, Jamroz, Ewa, Kaluzny, Lukasz, Pronicka, Ewa, Rokicki, Dariusz, Starostecka, Ewa, Sykut-Cegielska, Jolanta, Walczak, Mieczyslaw
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4789339/
https://www.ncbi.nlm.nih.gov/pubmed/27014570
http://dx.doi.org/10.1016/j.ymgmr.2015.12.002
_version_ 1782420835374465024
author Bik-Multanowski, Miroslaw
Jamroz, Ewa
Kaluzny, Lukasz
Pronicka, Ewa
Rokicki, Dariusz
Starostecka, Ewa
Sykut-Cegielska, Jolanta
Walczak, Mieczyslaw
author_facet Bik-Multanowski, Miroslaw
Jamroz, Ewa
Kaluzny, Lukasz
Pronicka, Ewa
Rokicki, Dariusz
Starostecka, Ewa
Sykut-Cegielska, Jolanta
Walczak, Mieczyslaw
author_sort Bik-Multanowski, Miroslaw
collection PubMed
description
format Online
Article
Text
id pubmed-4789339
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-47893392016-03-24 Patient's weight can decide about spending millions on enzyme replacement therapy in MPS II Bik-Multanowski, Miroslaw Jamroz, Ewa Kaluzny, Lukasz Pronicka, Ewa Rokicki, Dariusz Starostecka, Ewa Sykut-Cegielska, Jolanta Walczak, Mieczyslaw Mol Genet Metab Rep Correspondence Elsevier 2015-12-18 /pmc/articles/PMC4789339/ /pubmed/27014570 http://dx.doi.org/10.1016/j.ymgmr.2015.12.002 Text en © 2015 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Correspondence
Bik-Multanowski, Miroslaw
Jamroz, Ewa
Kaluzny, Lukasz
Pronicka, Ewa
Rokicki, Dariusz
Starostecka, Ewa
Sykut-Cegielska, Jolanta
Walczak, Mieczyslaw
Patient's weight can decide about spending millions on enzyme replacement therapy in MPS II
title Patient's weight can decide about spending millions on enzyme replacement therapy in MPS II
title_full Patient's weight can decide about spending millions on enzyme replacement therapy in MPS II
title_fullStr Patient's weight can decide about spending millions on enzyme replacement therapy in MPS II
title_full_unstemmed Patient's weight can decide about spending millions on enzyme replacement therapy in MPS II
title_short Patient's weight can decide about spending millions on enzyme replacement therapy in MPS II
title_sort patient's weight can decide about spending millions on enzyme replacement therapy in mps ii
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4789339/
https://www.ncbi.nlm.nih.gov/pubmed/27014570
http://dx.doi.org/10.1016/j.ymgmr.2015.12.002
work_keys_str_mv AT bikmultanowskimiroslaw patientsweightcandecideaboutspendingmillionsonenzymereplacementtherapyinmpsii
AT jamrozewa patientsweightcandecideaboutspendingmillionsonenzymereplacementtherapyinmpsii
AT kaluznylukasz patientsweightcandecideaboutspendingmillionsonenzymereplacementtherapyinmpsii
AT pronickaewa patientsweightcandecideaboutspendingmillionsonenzymereplacementtherapyinmpsii
AT rokickidariusz patientsweightcandecideaboutspendingmillionsonenzymereplacementtherapyinmpsii
AT starosteckaewa patientsweightcandecideaboutspendingmillionsonenzymereplacementtherapyinmpsii
AT sykutcegielskajolanta patientsweightcandecideaboutspendingmillionsonenzymereplacementtherapyinmpsii
AT walczakmieczyslaw patientsweightcandecideaboutspendingmillionsonenzymereplacementtherapyinmpsii